Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Repsonse to inhaled nitric oxide identifies a subset of patients with pulmonary hypertension likely to respond to high dose calcium channel antagonists

Repsonse to inhaled nitric oxide identifies a subset of patients with pulmonary hypertension likely to respond to high dose calcium channel antagonists. Crit Care Med. 1995; 151(4):A728.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.